42
55
Growth Score
-40 pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
128557
Cipla is a drug manufacturing company that focuses on a variety of pharmaceutical products.
Geena Malhotra: Global Chief Technology OfficerPast Role: Cipla, Head - Integrated Product Development
Ranjana Pathak: President - Global Quality, Medical Affairs and PharmacovigilancePast Role: Watson Pharmaceuticals, SVP - Global Quality
About the Company
Cipla is a drug manufacturing company that focuses on a variety of pharmaceutical products. Its focal areas are biologicals, small-molecule innovation, consumer healthcare, and regenerative medicine. Cipla maintains its focus on three main therapeutic areas: respiratory, urology, and antiretroviral. The bulk of its sales are generated in India,
although it maintains a large global presence. Cipla's growth strategy focuses on new product launches.
